Literature DB >> 4027397

Association of vaginal smear cytology with menstrual status in breast cancer.

R T Senie, S W Lobenthal, P P Rosen.   

Abstract

The relationship of clinically defined menstrual categories and an independent measure of hormonal stimulation, maturation index of vaginal smear cytology, was studied. Analysis of 596 smears obtained at the time of breast cancer diagnosis revealed a statistically significant association between menstrual status and maturation index. However, within each menstrual group varying levels of maturation were noted. Estrogenic effect in the absence of exogenous hormone administration was found in 11% of patients following bilateral oophorectomy and among 24% of women whose natural menopause occurred 20 years or longer prior to diagnosis. Endogenous estrogen production appears to continue for many years among some women. Clinical factors such as obesity, diabetes and/or hypertension may stimulate high squamous maturation in some patients. Others of the same age and with similar clinical histories were found to have atrophic smears. The differences in maturation index may be due to individual variations in: endogenous hormone levels; sensitivity of the vaginal mucosa to similar hormonal stimuli; use of certain medications; or unidentified exogenous factors. The maturation index was found to be significantly associated with the following prognostic factors: weight relative to height, tumor size and estrogen receptor content of the primary tumor. These findings indicate that vaginal smear cytology may define specific subsets within menstrual categories which may be relevant to therapy and prognosis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027397     DOI: 10.1007/bf01806025

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Geographic patterns of breast cancer in the United States.

Authors:  W J Blot; J F Fraumeni; B J Stone
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

2.  Epidemiology of breast carcinoma: Age, menstrual status, and exogenous hormone usage in patients with lobular carcinoma in situ.

Authors:  P P Rosen; R T Senie; G H Farr; D Schottenfeld; R Ashikari
Journal:  Surgery       Date:  1979-02       Impact factor: 3.982

3.  Vaginal cytology as an aid to hormone therapy in postmenopausal cancer of the breast.

Authors:  B A Stoll
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

4.  Breast cancer in premenopausal and postmenopausal women.

Authors:  K Stavraky; S Emmons
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age.

Authors:  D L Hemsell; J M Grodin; P F Brenner; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

6.  The menopause: a cytohormonal study.

Authors:  A Meisels
Journal:  Acta Cytol       Date:  1966 Jan-Feb       Impact factor: 2.319

7.  The DOM project for the early detection of breast cancer, Utrecht, The Netherlands.

Authors:  F de Waard; H J Collette; J J Rombach; E A Baanders-van Halewijn; C Honing
Journal:  J Chronic Dis       Date:  1984

8.  Association between estrogen receptors and weight in women with breast cancer.

Authors:  A E Papatestas; D Panveliwalla; D Pertsemlidis; M Mulvihill; A H Aufses
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

9.  Exogenous estrogens and other factors in the epidemiology of breast cancer.

Authors:  J L Kelsey; D B Fischer; T R Holford; V A LiVoisi; E D Mostow; I S Goldenberg; C White
Journal:  J Natl Cancer Inst       Date:  1981-08       Impact factor: 13.506

10.  Breast self-examination and medical examination related to breast cancer stage.

Authors:  R T Senie; P P Rosen; M L Lesser; D W Kinne
Journal:  Am J Public Health       Date:  1981-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.